Early Access Programmes Europe: the trade show
In order to meet the demand for these investigation drugs and ensure an equitable supply, sponsor companies are tasked with accurately anticipating demand and strategically planning to ensure they can successfully implement and execute these early access programs.
The event features professional speakers from pharmaceutical and biotechnology companies as well as regulatory authorities, patient advocated and HCPS; It is a platform to develop best practice to overcome challenge and understand the types of early access programs available and the different country regulations.